EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Evolving Pathology of Anaplastic Thyroid Carcinoma: Integrating Morphology, Immunohistochemistry, and Molecular Insights

Toru Odate iD, Tetsuo Kondo

Cancer Science · 2026-08 · 117 (8) · 2029-2039

DOI: 10.1111/cas.70427 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Science, online erschienen am 27.05.2026. Verfasst von Toru Odate und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Yamanashi, Yamanashi, Japan. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Thyroid Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Anaplastic thyroid carcinoma (ATC) is a rare malignancy characterized by an extremely aggressive clinical course, in contrast to the typically indolent behavior of most thyroid carcinomas. Recent advances in high‐throughput sequencing technologies have markedly enhanced our understanding of the genetic alterations underlying ATC. These molecular insights have also influenced current clinical management and pathologic classification. In diagnostic pathology, squamous cell carcinoma arising in the thyroid is now recognized as a histologic variant of ATC. The BRAF p.V600E mutation, detected in approximately half of ATCs, represents a clinically significant genetic alteration, as targeted therapies directed against this mutation have been associated with improved clinical outcomes. In addition to advances in molecular pathology, progress has also been made in diagnostic pathology, including expanded recognition of the histologic spectrum of ATC and the development of novel immunohistochemical markers. In this review, we summarize recent advances in the diagnostic and molecular pathology of ATC, aiming to provide both fundamental and practical insights for clinical practice. In diagnostic pathology, ATC often presents significant challenges because of its marked histologic heterogeneity and a broad differential diagnosis. Accordingly, this review provides an overview of both classical knowledge and recent molecular findings related to ATC and integrates these insights to present an updated framework for differential diagnosis and diagnostic approach. In addition, we discuss recent advances in immunohistochemistry, including mutation‐specific antibodies and novel diagnostic markers, and highlight their relevance in the context of contemporary diagnostic pathology and evolving therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Carcinoma, AnaplasticThyroid NeoplasmsHumansImmunohistochemistryProto-Oncogene Proteins B-rafMutationBiomarkers, TumorDiagnosis, Differential

Stichwörter der Autor:innen

BRAFanaplastic thyroid carcinomahistologyimmunohistochemistrypathology

Substanzen

Proto-Oncogene Proteins B-rafBiomarkers, TumorBRAF protein, human

Autor:innen und Institutionen

  • Department of Pathology, University of Yamanashi, Yamanashi, Japan.

ORCID-Profile: Toru Odate

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Odate, T., & Kondo, T. (2026). Evolving Pathology of Anaplastic Thyroid Carcinoma: Integrating Morphology, Immunohistochemistry, and Molecular Insights. Cancer Science, 117(8), 2029-2039. https://doi.org/10.1111/cas.70427

Vancouver

Odate T, Kondo T. Evolving Pathology of Anaplastic Thyroid Carcinoma: Integrating Morphology, Immunohistochemistry, and Molecular Insights. Cancer Science. 2026;117(8):2029-2039. doi:10.1111/cas.70427

BibTeX
@article{Odate2026,
  author = {Odate, Toru and Kondo, Tetsuo},
  title = {Evolving Pathology of Anaplastic Thyroid Carcinoma: Integrating Morphology, Immunohistochemistry, and Molecular Insights},
  journal = {Cancer Science},
  year = {2026},
  volume = {117},
  number = {8},
  pages = {2029--2039},
  doi = {10.1111/cas.70427}
}
Kostenlos starten →